Company: LNAI
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001731122-25-001544
Chunk: 4

Company: Lunai Bioworks Inc.
Filing Date: 2025-11-14
Form: 10-Q
Item: Part I, Item 1
Chunk 4
---
,212,036
)

ADJUSTMENTS TO RECONCILE NET INCOME (LOSS) TO NET CASH USED IN OPERATING ACTIVITIES:

Depreciation and amortization

41,522

32,385

Loss on extinguishment of debt

6,329,593

—

Change in value of contingent consideration

(370,000
)

(9,250,000
)

Change in value of equity securities

(156,849
)

Stock-based compensation expense

181,312

357,648

Gain on bankruptcy of subsidiary

(12,019,227
)

1,400,000

Long-lived asset impairment

831,915

47,614,729

Gain on settlement of accounts payable

(22,324
)

—

Amortization of debt issuance cost

18,495

—

Amortization of discount of notes payable

—

23,718

Changes in assets and liabilities:

Other receivables

(6,407
)

(195,961
)

Prepaid expenses/deposits

269,264

183,701

Accounts payable

532,206

1,953,539

Accrued expenses

205,738

46,891

Other current liabilities

—

31,325

Operating leases, net

(3,369
)

(2,269
)

NET CASH USED IN OPERATING ACTIVITIES

(1,349,110
)

(2,016,328
)

CASH FLOWS FROM INVESTING ACTIVITIES:

Sale of equitable securities

544,700

—

NET CASH USED IN INVESTING ACTIVITIES

544,700

—

CASH FLOWS FROM FINANCING ACTIVITIES:

Repayment of finance agreement

(271,643
)

(223,945
)

Proceeds from private placement

—

2,096,181

Proceeds from notes payable

1,615,000

156,947

NET CASH PROVIDED BY FINANCING ACTIVITIES

1,343,357

2,029,183

Effect of exchange rates on cash

(6,839
)

(12,751
)

NET CHANGE IN CASH

532,108

104

CASH, BEGINNING OF PERIOD

92,700

220,467

CASH, END OF PERIOD
 
$
624,808

$
220,571

SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION

Cash paid during the period for